RESUMO
The first global outbreak of monkeypox in non-epidemic regions occurred in May 2022, and the World Health Organization defined it as a public health emergency of international concern in July 2022. Compared with previous outbreaks of monkeypox in Africa, the current one is different in etiology, epidemiology and clinical characteristics. This article reviews the features of the latest outbreak of monkeypox, and the currently available antiviral treatment and vaccines, so as to provide reference for the prevention and treatment of monkeypox.
RESUMO
Eight patients with malignant tumors, testified by pathological examination. were treated by " Two-Route Chemotherapy" using a high dose of HD-Cisp latine in arterial infusion (AI). Among them 5 cases were primary or metastatic liver carcinoma, 3 cases were Ⅲ-Ⅳ stage breast carcinoma.One or two courses were given in each patient. The dosage of DDP in the first course was 80 - 100mg/m~2. the second was 120-150mg/m~2 with STS Ⅳ as a protective agent. The total lasted 14 courses.When DDF was given alone in AI, the serum creatine level increased temporarily, but there was no significant increase when both DDP and sodi um thiosulfate were given.Results: Among 5 cases of liver carcinomas I was complete response 3 were partial response and 1 was stable. Among 3 cases of Ⅲ-Ⅳ stage of breast carcinomas, all were partial response, giving a response rate of 8 (?) (7/8).